Complete Story
 

02/27/2013

AVASTIN (bevacizumab)

Now approved for a new indication

In combination with fluoropyrimidine-irinotecan or fluoropyrimidine-oxaliplatin-based chemotherapy, for the second-line treatment of patients with metastatic colorectal cancer who have progressed on a first-line Avastin-containing regimen. To read more CLICK HERE